期刊文献+

透明质酸衍生物微球/微囊的制备及其生物医学应用进展 被引量:5

Preparation of Hyaluronan Based Microspheres/microcapsules and Their Application Advancement in Biomedical Field
下载PDF
导出
摘要 天然蛋白多糖透明质酸(HA)具有非免疫原性,在药物及基因的控制传递方面有理想的生物相容性。然而,HA的亲水性限制了其作为药物载体的应用广度,因此需要经过化学修饰改善其物理特性,同时保持其生物相容性,使其更好地胜任药物载体的角色。此外,HA与多种聚合物的复合物在性能上相互补充和促进,复合材料的载体也显示出更优越的特性。本文针对目前HA、HA衍生物及其复合物微球/微囊的制备方法、应用现状和发展前景进行了综述。 Hyaluronan (HA) is a kind of non-immtmogenic glycosaminoglycans in extracellular matrix, and has wonderful biocompatibility, which is promising to be developed as drug carriers to realize controlled release. However, the hydrophilicity of HA confines its application as drug carriers, HA should be chemical modified to advance its physical properties and simultaneously remaining its biocompatibility. Furthermore, HA and some other polymers earl retrieve and promote the characteristics of each other, and thereby the compound shows better properties. In this review, we summarize the preparation technique, the current application fields and the development of the mierospheres/microcapsules of HA, HA derivatives and the compounds.
出处 《透析与人工器官》 2007年第4期18-24,共7页 Chinese Journal of Dialysis and Artificial Organs
关键词 透明质酸 交联 酯化 微球 微囊 药物释放体系 控制释放 hyaluronan cross-linking esterification microspheres microcapsules drug delivery system controlled release
  • 相关文献

参考文献47

  • 1Miner RA, Brady JM, Cutright DE. Degradation rates of oral resorbale implants: rat modification with changes in PLA/PGA copolymer ratios [J]. Biomed Mater Res, 1987,11:711- 717.
  • 2Prestwich GD, Marecak DM, Marecek JF, et al. Chemical modification of hyaluronic acid for drug delivery, biomaterials, and biochemical probes [M]. Lauret TC. The chemistry, biology, anad medical applications of hyaluronan and its derivatives. Miami, FL, USA- Portland Press, 1998:43-65.
  • 3Fraser JR, Brown TJ, Laurent TC. Catabolism of hyaluronan [M]. Laurent TC. The chemistry, biology, and medical applications of hyaluronan and medical applications of hyaluronan and its derivatives. Miami, FL, USA: Portland Press, 1998:85-92.
  • 4Laurent TC, Fraser JR. Hyaluronan[J]. FASEB J,1992,6 (7): 2397- 2404.
  • 5Toole BP. Hyaluronan and its binding proteins, the hyaladherins [J]. Curr Opin Cell Biol, 1990,2 (5) : 839-844.
  • 6Scott JE. Extracellular matrix, supramolecular organization and shape[J]. J Anat, 1995,187 (pt2) :259-269.
  • 7Hardwick C, Hoare K, Owens R, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility[J]. J Cell Biol, 1992,117 : 1343-1350.
  • 8Collis L, Hall C, Lange L, et al. Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action[J]. FEBS Lett, 1998,440 : 444- 449.
  • 9Toole BP. Hyaluronan in morphogenesis [J]. J Intern Med, 1997, 242 : 35-40.
  • 10Gerdin B,Hallgem R. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation[J]. J Intern Med,1997,242 : 49-55.

共引文献3

同被引文献61

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部